Loading...

Blog Article

FMRP and Fragile X Syndrome
Fragile X Syndrome (FXS) is the most commonly inherited cause of intellectual disability. Specific FXS symptoms include mental retardation, muscle spasms, seizures, and several other physiological changes. FXS is mainly attributed to a change in the FMR1 gene, which produces Fragile X mental retardation protein (FMRP). BioLegend provides reagents for FMRP detection and highlights the study conducted by Saldarriaga, et al. looking into the mechanism of why FMRP fails and how it affects those who develop FXS.
Adapted from: Saldarriaga, W. et al. 2014. Colomb. Med (Cali). 4:190. PubMed
FXS occurs when the FMR1 gene undergoes an expansion in the number of CGG nucleotide repeats in its 5' UTR region. Normally, the amount of repeats is between 55 to 200. However, when this number goes over 200, the CpG islands are recognized by methyl transferases, methylated, and silenced. Histone deacetylases are then recruited and condense the chromatin, restricting access to the affected area. Without FMRP, several other neuronal proteins are made, leading to weakened synapses, neuronal hyperexcitability, and FXS.

Related Antibodies
Description Clone Cat. No.
Purified anti-FMRP Antibody 5C2 834701
Purified anti-FMRP Antibody 6B8/FMRP 834601

FMRP Data
Reactivity of clone 6B8/FMRP to cell lysates of lymphoblastoid cell lines derived from normal (C) and male FX full mutation (FM) individuals at a 1:2000 dilution showing the protein is not present in fragile X individuals but present in normal subjects. Western Blot showing human and murine specificity of clone 6B8/FMRP using human and mouse brain cortex lysates at a 1:2000 dilution. (Images courtesy of R. Kascsak)
*Any references to promotions on this page may not be valid at this time. View our promotions page for the most up-to-date promotions.
Related Pages
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account